News & Events
Wednesday, May 22, 2013
Soligenix Announces Issuance of US Patent for its ThermoVax™ Technology
[read more]Tuesday, May 14, 2013
Soligenix Initiates Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohn’s Disease
[read more]Friday, May 03, 2013
Soligenix Reports First Quarter 2013 Financial Results and Highlights Recent Accomplishments
[read more]Wednesday, May 01, 2013
Soligenix and Intrexon Pursue Melioidosis Therapy Through Worldwide Exclusive Collaboration
[read more]Tuesday, April 16, 2013
Soligenix to Present at World Vaccine Congress & Expo
[read more]Wednesday, March 27, 2013
Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate SGX942 for the Treatment of Oral Mucositis
[read more]Tuesday, March 19, 2013
Soligenix Announces Significant Progress with ThermoVax™ Towards the Development of Heat Stable Vaccines
[read more]Tuesday, February 26, 2013
Soligenix Reports Year-End 2012 Financial Results and Highlights Recent Accomplishments
[read more]Wednesday, February 20, 2013
Soligenix Submits BARDA Contract Proposal for Development of OrbeShieldTM in GI ARS
[read more]Friday, February 08, 2013
Soligenix to Present at 15th Annual BIO CEO & Investor Conference
[read more]Monday, February 04, 2013
Soligenix Announces Formation of Oral Mucositis Medical Advisory Board
[read more]
